Literature DB >> 23319133

The neuro-critical care management of the endovascular stroke patient.

Vishal N Patel1, Rishi Gupta, Christopher M Horn, Tommy T Thomas, Raul G Nogueira.   

Abstract

OPINION STATEMENT: Acute ischemic stroke carries high morbidity and mortality. The advent of intravenous thrombolysis and endovascular reperfusion techniques have helped improve clinical outcomes for patients with large vessel acute ischemic stroke. The care of the post-endovascular stroke patient is complex and encompasses almost all aspects of medicine. Hemodynamics should be optimized post procedure to ensure adequate cerebral perfusion and strict hemodynamic parameters must be adhered to minimize reperfusion injury. Though no studies have specifically examined hemodynamic goals, our practice is to maintain a mean arterial pressure (MAP) > 70 and systolic blood pressure (SBP) < 140 for patients following successful recanalization. Early anti-thrombotic therapy is indicated in patients with stent placement. It remains less clear which patients may benefit from additional anticoagulation or therapy with IIb/IIIa inhibitors. Careful consideration must be paid to volume status to reduce risk of contrast nephropathy and maximize cerebral perfusion. Oral care and attention to dysphagia are key in preventing aspiration pneumonia. Glycemic control should be optimized to avoid excessive hyper and hypoglycemia. In the absence of data to guide treatment of anemia, our practice is to transfuse asymptomatic anemia when Hgb < 7 mg/dL, or if the patient is symptomatic or hemodynamically unstable. Neuro-protective strategies should be considered in the context of clinical trials until further studies are complete. At a minimum, fever should be treated aggressively. Young patients with good pre-morbid functional status who continue to have large volume infarcts may benefit from decompressive hemicraniectomy. When appropriate, aggressive and early mobilization is recommended to prepare patients for acute rehabilitation. Because randomized prospective data is lacking, patients should be encouraged to enroll in clinical trials to optimize care of this growing patient population.

Entities:  

Year:  2013        PMID: 23319133     DOI: 10.1007/s11940-012-0216-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  66 in total

Review 1.  Management of bleeding complications in the anticoagulated patient.

Authors:  Vinai C Bhagirath; Lauren O'Malley; Mark A Crowther
Journal:  Semin Hematol       Date:  2011-10       Impact factor: 3.851

2.  Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?

Authors:  Deepak L Bhatt
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

Review 3.  Reperfusion brain injury: focus on cellular bioenergetics.

Authors:  Svetlana Pundik; Kui Xu; Sophia Sundararajan
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

4.  Basal ganglionic infarction before mechanical thrombectomy predicts poor outcome.

Authors:  Yince Loh; Amytis Towfighi; David S Liebeskind; David L MacArthur; Paul Vespa; Nestor R Gonzalez; Satoshi Tateshima; Sidney Starkman; Jeffrey L Saver; Zhong-Song Shi; Reza Jahan; Fernando Viñuela; Gary R Duckwiler
Journal:  Stroke       Date:  2009-08-06       Impact factor: 7.914

5.  Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score.

Authors:  Alexander C Flint; S P Cullen; B S Faigeles; V A Rao
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-11       Impact factor: 3.825

Review 6.  Symptomatic and palliative care for stroke survivors.

Authors:  Claire J Creutzfeldt; Robert G Holloway; Melanie Walker
Journal:  J Gen Intern Med       Date:  2012-01-19       Impact factor: 5.128

7.  Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.

Authors:  Jean-Philippe Collet; Jean-Sébastien Hulot; Anna Pena; Eric Villard; Jean-Baptiste Esteve; Johanne Silvain; Laurent Payot; Delphine Brugier; Guillaume Cayla; Farzin Beygui; Gilbert Bensimon; Christian Funck-Brentano; Gilles Montalescot
Journal:  Lancet       Date:  2008-12-26       Impact factor: 79.321

8.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

9.  Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke.

Authors:  Andrew D Barreto; Karen C Albright; Hen Hallevi; James C Grotta; Elizabeth A Noser; Aslam M Khaja; Hashem M Shaltoni; Nicole R Gonzales; Kachi Illoh; Sheryl Martin-Schild; Morgan S Campbell; Raymond U Weir; Sean I Savitz
Journal:  Stroke       Date:  2008-09-04       Impact factor: 7.914

10.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

Authors:  Craig S Anderson; Yining Huang; Ji Guang Wang; Hisatomi Arima; Bruce Neal; Bin Peng; Emma Heeley; Christian Skulina; Mark W Parsons; Jong Sung Kim; Qing Ling Tao; Yue Chun Li; Jian Dong Jiang; Li Wen Tai; Jin Li Zhang; En Xu; Yan Cheng; Stephane Heritier; Lewis B Morgenstern; John Chalmers
Journal:  Lancet Neurol       Date:  2008-04-07       Impact factor: 44.182

View more
  1 in total

1.  Blood pressure management in stroke: Five new things.

Authors:  Ritvij Bowry; Digvijaya D Navalkele; Nicole R Gonzales
Journal:  Neurol Clin Pract       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.